B2M and neoplasm: Following CD4+ T cell stimulation, CD8+ cytotoxic lymphocytes (CTLs) activate the T cell mediated immune response, resulting in the killing of tumour cells, as a result of the interaction between TCR molecules and the MHC class I complex αβ dimer and β2 microglobulin (B2M).